Results 91 to 100 of about 1,751 (120)

A Systematic Review of Medical Treatments for Benign Prostatic Hyperplasia in Dogs: Evaluating Strategies for Reproductive Function Preservation. [PDF]

Vet Sci
Posastiuc FP, Constantin NT, Domain G, Soom AV, Diaconescu AI, Codreanu MD.   +5 more
europepmc   +1 more source

Using 5 alpha reductase inhibitors safely: What primary care physicians need to know. [PDF]

J Family Med Prim Care
Meenrajan SR.
europepmc   +1 more source

Management of women with hirsutism in Kosovo. [PDF]

Postepy Dermatol Alergol
Lumezi BG, Lokaj-Berisha V.
europepmc   +1 more source

Research progress in the treatment of non-scarring alopecia: mechanism and treatment. [PDF]

Front Pharmacol
Guo RX, Zhao YK, Hu KJ, Jia KM, Shi W, Yi YX, Gong HY, Wang JB, Gao Y.   +8 more
europepmc   +1 more source

Case Report: Acupuncture for acute colonic pseudo- obstruction in a 90-year-old patient with COVID-19 infection. [PDF]

Front Med (Lausanne)
Liao B, Ren M, Zhao Y, Rong J.
europepmc   +1 more source

Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series.

Int J Trichology
Chandrashekhar M, Chandrashekar BS, Madura C, Shenoy C.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Post-Finasteride Syndrome. Literature Review

Archivos Españoles de Urología, 2022
Post-finasteride syndrome (PFS) is a little known adverse effect of 5α-reductase inhibitor (5-ARI) drugs used in benign prostatic hyperplasia (BPH) and androgenetic alopecia. Five articles on the syndrome have been published in Spain, although no review has been published.The objectives of this article are to review the world literature, including the ...
openaire   +2 more sources

Das Post-Finasterid-Syndrom

Gynäkologische Endokrinologie, 2017
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire   +1 more source

The post-finasteride syndrome: possible etiological mechanisms and symptoms

International Journal of Impotence Research, 2023
Finasteride and dutasteride, synthetic 5α-reductase inhibitors (5ARIs) are recommended in many guidelines for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms and alopecia despite a variety of side effects like sexual, neurological, psychiatric, endocrinological, metabolic and ophthalmological dysfunctions and the increased ...
Herman H. J. Leliefeld, Frans M. J. Debruyne, Yakov Reisman   +2 more
openaire   +2 more sources

(122) Erectile Hemodynamics Asessment In ED Patients With Self-Diagnosed Post-finasteride syndrome (PFS)

The Journal of Sexual Medicine, 2023
Abstract Introduction Much debate exists regarding the concept of PFS and its etiology. There exists data suggesting abnormal erectile hemodynamic alterations in this population. Objective This analysis was performed to define ...
S Deveci, J F Sullivan, R Tal, J P Mulhall   +3 more
openaire   +1 more source